Optimising Glycaemic Control with Automated Glucose Monitoring: Impact on Hospital Length of Stay and Surgical Outcomes in Patients with Diabetes Mellitus

Not Applicable

• Conditions: Diabetes mellitus; Hyperglycaemia; Hypoglycaemia; Surgical site infections; Hospital admission; Hospital readmission; Metabolic and Endocrine - Diabetes; Infection - Other infectious diseases; Public Health - Other public health

• Registration Number: ACTRN12624000787583
• Lead Sponsor: epean Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-26
• Last Update Posted: 8 July 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Adults who are admitted on the surgical wards at Nepean Hospital with pre-existing diabetes (type 1, type 2 or other types of diabetes, excluding gestational diabetes) treated with diet alone, oral tablets or injectable therapy (e.g. insulin, GLP-1 agonists), who require regular blood glucose testing as part of the standard clinical care, including those already on continuous glucose monitoring.

Exclusion Criteria

1. Age under 16 years
2. Patients admitted under a non-surgical team
3. Patients with gestational diabetes or without diabetes
4. Blood glucose measurements by nursing staff who are not trained to use the different types of glucometers (e.g. agency nurses, nursing students)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in percentage of time during which the BGL is in the target range of 5-10mmol/L. I.e. percentage of time in range (TIR) [Via glucose meter BGLs throughout the patient participant admission will be assessed for TIR at the end of the hospital inpatient stay ]